Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105175327B reveals AgOTf catalyzed quinoline synthesis offering high purity and cost reduction in pharmaceutical intermediate manufacturing for global supply chains.
Patent CN101792438A details a copper-catalyzed decarboxylative coupling for high-purity triazole intermediates, offering cost-effective manufacturing solutions.
Patent CN110117237B reveals a mild nickel-catalyzed cyanation method for aromatic nitriles. This technology offers significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN110683926B reveals a robust Pd-catalyzed method for direct C-O coupling, offering high yields and broad substrate scope for reliable pharmaceutical intermediate manufacturing.
Patent CN107602452B reveals a one-pot copper-catalyzed method for 3-acyl pyridines, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel Mo/Cu co-catalyzed method for high-purity triazole intermediates. Reduces steps and costs for API manufacturing with mild conditions.
Novel copper-catalyzed route for high-purity quinazolinone intermediates. Enhanced yield and fluorescence sensing applications for industrial procurement and supply chain stability.
Patent CN110467555B reveals a chiral phosphoric acid catalyzed route for high-purity axial chiral aryl indoles, offering cost-effective API intermediate manufacturing.
Patent CN112898192B reveals a safe, one-pot carbonylation route for N-acyl indoles using solid CO sources, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN114195711B reveals efficient Pd-catalyzed carbonylation. Delivers high-purity quinoline-4(1H)-one with substantial cost reduction and supply chain reliability.
Novel nickel-catalyzed carbonylation method for indole synthesis offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Metal-free heating method for quinoline intermediates. Reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Novel Pd-catalyzed carbonylation method offers high yields and broad substrate scope for cost-effective API intermediate manufacturing.
Patent CN113845481A details a copper-catalyzed route to pyridazinone intermediates, offering safer alternatives to hydrazine for reliable pharmaceutical manufacturing.
Patent CN104447440B reveals Mn-catalyzed asymmetric oxidation. High purity, green process, supply chain reliability for pharma intermediates.
Novel iodine-promoted synthesis of 5-trifluoromethyl-1,2,4-triazoles. Cost-effective, scalable route for API intermediates without heavy metals.
This patent details a copper-catalyzed synthesis for 1-naphthylamine derivatives offering high yields. It enables cost reduction and scalable manufacturing for reliable pharmaceutical intermediate suppliers globally.
Patent CN113045489A reveals a novel Pd-catalyzed aminocarbonylation route for high-purity API intermediates, offering significant cost reduction and scalable manufacturing.
Novel one-pot synthesis for 9H-pyrimido[4,5-b]indoles using copper catalysis. Reduces steps and cost for pharmaceutical intermediates.
Patent CN114539198B reveals a novel Pd-catalyzed route for chroman amides, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.